Ameriprise’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.53M Sell
31,755
-361
-1% -$16K ﹤0.01% 3088
2025
Q4
$1.32M Sell
32,116
-1,430
-4% -$57.4K ﹤0.01% 3210
2025
Q3
$1.3M Buy
33,546
+1,289
+4% +$41.9K ﹤0.01% 3229
2025
Q2
$893K Sell
32,257
-5,014
-13% -$128K ﹤0.01% 3317
2025
Q1
$828K Sell
37,271
-13,805
-27% -$284K ﹤0.01% 3283
2024
Q4
$1.01M Sell
51,076
-124,245
-71% -$2.84M ﹤0.01% 3232
2024
Q3
$4.38M Buy
+175,321
New +$4.27M ﹤0.01% 2469
2024
Q2
Sell
-117,231
Closed -$2.31M 3908
2024
Q1
$2.31M Sell
117,231
-48,054
-29% -$939K ﹤0.01% 2798
2023
Q4
$2.9M Sell
165,285
-181,582
-52% -$2.98M ﹤0.01% 2686
2023
Q3
$6.03M Sell
346,867
-24,408
-7% -$411K ﹤0.01% 2143
2023
Q2
$5.23M Sell
371,275
-237
-0.1% -$3.17K ﹤0.01% 2315
2023
Q1
$4M Buy
371,512
+14,896
+4% +$196K ﹤0.01% 2467
2022
Q4
$5.34M Sell
356,616
-17,374
-5% -$253K ﹤0.01% 2244
2022
Q3
$4.8M Buy
+373,990
New +$4.26M ﹤0.01% 2259
2021
Q2
Sell
-1,371,430
Closed -$25.4M 3931
2021
Q1
$25.4M Sell
1,371,430
-999,806
-42% -$20.5M 0.01% 1143
2020
Q4
$41.9M Buy
2,371,236
+235,977
+11% +$4.15M 0.01% 823
2020
Q3
$32.7M Buy
2,135,259
+646,420
+43% +$12.1M 0.01% 817
2020
Q2
$37.9M Buy
1,488,839
+837,770
+129% +$17.5M 0.02% 719
2020
Q1
$10.1M Sell
651,069
-498,509
-43% -$7.8M 0.01% 1381
2019
Q4
$12.7M Buy
1,149,578
+477,940
+71% +$4.15M 0.01% 1557
2019
Q3
$5.72M Sell
671,638
-74,372
-10% -$822K ﹤0.01% 2123
2019
Q2
$10.1M Buy
746,010
+211,385
+40% +$3.28M ﹤0.01% 1726
2019
Q1
$9.66M Buy
534,625
+231,985
+77% +$4.48M ﹤0.01% 1731
2018
Q4
$8.5M Sell
302,640
-67,042
-18% -$1.4M ﹤0.01% 1731
2018
Q3
$9.43M Sell
369,682
-352,609
-49% -$6.86M ﹤0.01% 1903
2018
Q2
$12.5M Buy
+722,291
New +$13.1M 0.01% 1554

Other funds holding KNSA